Nanotechnology and its relationship to interventional radiology. Part II: Drug delivery, thermotherapy, and vascular intervention

CardioVascular and Interventional Radiology

Volumn 34, Issue 4, 2011, Pages 676-690

  Power, Sarah ^a   Slattery, Michael M ^a   Lee, Michael J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Angiogenesis; Drug delivery; Nanoparticle; Nanotechnology; Restenosis; Thermotherapy

Indexed keywords

ALCOHOL; CHITOSAN; CISPLATIN; DIDODECYLDIMETHYLAMMONIUM BROMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FERUCARBOTRAN; FLUOROURACIL; FUMAGILLIN; GADOLINIUM; GONADORELIN; IODINATED POPPYSEED OIL; LIPOSOME; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; NANOBUBBLE; NANOMATERIAL; PACLITAXEL; POLITEF; POLYAMIDOAMINE; POLYGLACTIN; RICINOMACROGOL; SINGLE WALLED NANOTUBE; STREPTOKINASE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TISSUE PLASMINOGEN ACTIVATOR;

ADJUVANT THERAPY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BIOCOMPATIBILITY; BIOENGINEERING; BLOOD CLOT LYSIS; BLOOD VESSEL WALL; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG ELUTING STENT; GLIOMA; GRANULOMA; HEAD AND NECK CARCINOMA; HEMOSTASIS; HUMAN; HYPERSENSITIVITY REACTION; HYPERTHERMIC THERAPY; IN-STENT RESTENOSIS; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVENTIONAL RADIOLOGY; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MUSCLE CANCER; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY ABLATION; REVIEW; SARCOMA; SENSORY NEUROPATHY; THROMBOSIS; TOXICITY TESTING; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CATHETER ABLATION; DRUG DELIVERY SYSTEMS; HEMOSTATIC TECHNIQUES; HUMANS; HYPERTHERMIA, INDUCED; MAGNETITE NANOPARTICLES; MUSCLE, SMOOTH, VASCULAR; NANOTECHNOLOGY; NEOPLASMS; RADIOLOGY, INTERVENTIONAL; STENTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 79960915776     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9967-y     Document Type: Review

References (129)

1. B Haley E Frenkel 2008 Nanoparticles for drug delivery in cancer treatment Urol Oncol 26 57 64 18190833 1:CAS:528:DC%2BD1cXlsVWqtQ%3D%3D
2. OC Farokhzad R Langer 2006 Nanomedicine: developing smarter therapeutic and diagnostic modalities Adv Drug Deliv Rev 58 1456 1459 17070960 1:CAS:528:DC%2BD28Xht1KmtLnF (Pubitemid 44820502)
3. AD Bangham MM Standish JC Watkins 1965 Diffusion of univalent ions across the lamellae of swollen phospholipids J Mol Biol 13 238 252 5859039 1:CAS:528:DyaF2MXkvVWru7g%3D
4. DA Tomalia LA Reyna S Svenson 2007 Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem Soc Trans 35 61 67 17233602 1:CAS:528:DC%2BD2sXit1OksLc%3D
5. R Shukla TP Thomas JL Peters, et al. 2006 HER2 specific tumor targeting with dendrimer conjugated Anti-HER2 mAb Bioconjug Chem 17 1109 1115 16984117 1:CAS:528:DC%2BD28XotV2ltb0%3D (Pubitemid 44455317)
6. T Uwatoku H Shimokawa K Abe, et al. 2003 Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats Circ Res 92 e62 e69 12663484 1:CAS:528:DC%2BD3sXislCgurY%3D
7. C Jin L Bai H Wu, et al. 2007 Radiosensitization of paclitaxel, etanidazole, and paclitaxel + etanidazole nanoparticles on hypoxic human tumour cells in vitro Biomaterials 28 3724 3730 17509678 1:CAS:528:DC%2BD2sXmt1Gqtr4%3D (Pubitemid 46855881)
8. X Li R Li X Qian, et al. 2008 Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate Eur J Pharm Biopharm 70 726 734 18634874 1:CAS:528: DC%2BD1cXhtlags7fJ
9. A Krishnadas I Rubinstein H Onyüksel 2003 Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs Pharm Res 20 297 302 12636171 1:CAS:528: DC%2BD3sXpslWhsQ%3D%3D (Pubitemid 36269739)
10. JH Thrall 2004 Nanotechnology and medicine Radiology 230 315 318 14752175 (Pubitemid 38133784)
11. R Gordon D Losic MA Tiffany, et al. 2009 The glass menagerie: diatoms for novel applications in nanotechnology Trends Biotechnol 27 116 127 19167770 1:CAS:528:DC%2BD1MXhtlShur8%3D
12. B Chertok BA Moffat AE David, et al. 2008 Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumours Biomaterials 29 487 496 17964647 1:CAS:528:DC%2BD2sXhtlWmsrjN (Pubitemid 350100794)
13. SJ Son J Reichel B He, et al. 2005 Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery J Am Chem Soc 127 7316 7317 15898772 1:CAS:528:DC%2BD2MXjslKqt78%3D (Pubitemid 40746010)
14. I Brigger C Dubernet P Couvreur 2002 Nanoparticles in cancer therapy and diagnosis Adv Drug Deliv Rev 54 631 651 12204596 1:CAS:528:DC%2BD38XmsVeqtrs%3D (Pubitemid 35247520)
15. F Alexis J Rhee JP Richie, et al. 2008 New frontiers in nanotechnology for cancer treatment Urol Oncol 26 74 85 18190835 1:CAS:528: DC%2BD1cXlsVWquw%3D%3D
16. JR Heath ME Davis 2008 Nanotechnology and cancer Annu Rev Med 59 251 265 17937588 1:CAS:528:DC%2BD1cXis12nur8%3D (Pubitemid 351287936)
17. P Couvreur C Vauthier 2006 Nanotechnology: intelligent design to treat complex disease Pharm Res 23 1417 1450 16779701 1:CAS:528:DC%2BD28XmsFOmuro%3D (Pubitemid 43993807)
18. S Kim YT Lim EG Soltesz, et al. 2004 Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping Nat Biotechnol 22 93 97 14661026 1:CAS:528:DC%2BD2cXls1ej (Pubitemid 38057962)
19. A Pope-Harmon MM Cheng F Robertson, et al. 2007 Biomedical nanotechnology for cancer Med Clin North Am 91 899 927 (Pubitemid 47361211)
20. Nie S, Y. X, Kim GJ, et al. (2007) Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257-288 (Pubitemid 350246658)
21. YL Koo GR Reddy M Bhojani, et al. 2006 Brain cancer diagnosis and therapy with nanoplatforms Adv Drug Deliv Rev 58 1556 1577 17107738 1:CAS:528:DC%2BD28Xht1KmtLfN (Pubitemid 44820505)
22. KY Kim 2007 Nanotechnology platforms and physiological challenges for cancer therapeutics Nanomedicine 3 103 110 17442621 1:CAS:528: DC%2BD2sXnsVOrtLo%3D (Pubitemid 46899612)
23. OM Koo I Rubinstein H Onyuksel 2005 Role of nanotechnology in targeted drug delivery and imaging: aconcise review Nanomedicine 1 193 212 17292079 1:CAS:528:DC%2BD2MXht1Cgt7nI (Pubitemid 43963632)
24. M Harries P Ellis P Harper 2005 Nanoparticle albumin-bound paclitaxel for metastatic breast cancer J Clin Oncol 23 7768 7771 16204007 1:CAS:528:DC%2BD2MXht1Cqs7nN (Pubitemid 46657369)
25. B Damascelli G Patelli V Tichá, et al. 2007 Feasibility and efficacy of percutaneous transcatheter intrarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx J Vasc Interv Radiol 18 1395 1403 18003990 (Pubitemid 47625995)
26. K Na YH Bae 2002 Self-Assembled hydrogel nanoparticles responsive to tumor extracellular ph from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro Pharm Res 19 681 688 12069173 1:CAS:528:DC%2BD38XksFCisbg%3D (Pubitemid 34553678)
27. GR Reddy MS Bhojani P McConville, et al. 2006 Vascular targeted nanoparticles for imaging and treatment of brain tumours Clin Cancer Res 12 6677 6686 17121886 1:CAS:528:DC%2BD28Xht1elsL%2FP (Pubitemid 44876835)
28. CE Soma C Dubernet D Bentolila, et al. 2000 Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles Biomaterials 21 1 7 10619673 1:CAS:528:DC%2BD3cXjtVeqsQ%3D%3D
29. K Nakano K Egashira S Masuda, et al. 2009 Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries JACC: Cardiovasc Interv 2 277 283
30. Y Matsumura H Maeda 1986 A New concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accummulation of proteins and the antitumour agents Smancs Cancer Res 46 6387 6392 2946403 1:CAS:528:DyaL2sXnvVensA%3D%3D (Pubitemid 17221789)
31. H Maeda J Wu T Sawa, et al. 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 1-2 271 284 10699287 1:CAS:528:DC%2BD3cXhtl2qsLo%3D (Pubitemid 30122932)
32. L Mu SS Feng 2003 A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J Control Release 86 33 48 12490371 1:CAS:528:DC%2BD38XpsFSjsro%3D (Pubitemid 35469120)
33. B Damascelli G Cantù F Mattavelli, et al. 2001 Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity Cancer 92 2592 2602 11745194 1:CAS:528:DC%2BD3MXovVWnurc%3D (Pubitemid 33049443)
34. J Zhou C Leuschner C Kumar, et al. 2006 Sub-cellular accummulation of magnetic nanoparticles in breast tumors and metastases Biomaterials 27 2001 2008 16280161 1:CAS:528:DC%2BD2MXht12isLfM (Pubitemid 41759493)
35. DLJ Thorek AK Chen J Czupryna, et al. 2006 Superparamagnetic iron oxide nanoparticle probes for molecular imaging Ann Biomed Eng 34 23 38 16496086
36. A Moore E Marecos A Bogdanov, et al. 2000 Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model Radiology 214 568 574 10671613 1:CAS:528:DC%2BD3cXpvF2rtw%3D%3D (Pubitemid 30077721)
37. L Barraud P Merle E Soma, et al. 2005 Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo J Hepatol 42 736 743 15826724 1:CAS:528:DC%2BD2MXjtFyktLk%3D
38. G Storm SO Belliot T Daemen, et al. 1995 Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv Drug Deliv Rev 17 31 48 1:CAS:528:DyaK2MXps1Wltbk%3D
39. A Gabizon R Catane B Uziely, et al. 1994 Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res 54 987 992 8313389 1:CAS:528:DyaK2cXhslegs70%3D (Pubitemid 24085451)
40. SK Sahoo W Ma V Labhasetwar 2004 Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer Int J Cancer 112 335 340 15352049 1:CAS:528:DC%2BD2cXnvVejsbs%3D (Pubitemid 39244375)
41. CP Leamon JA Reddy 2004 Folate-targeted chemotherapy Adv Drug Deliv Rev 56 1127 1141 15094211 1:CAS:528:DC%2BD2cXjtF2rtLw%3D (Pubitemid 38496512)
42. H Tokumitsu J Hiratsuka Y Sakurai, et al. 2000 Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor Cancer Lett 150 177 182 10704740 1:CAS:528:DC%2BD3cXhsVahsr0%3D (Pubitemid 30125852)
43. GB Lesinski S Sharma KA Varker, et al. 2005 Release of biologically functional interferon-alpha from a nanochannel delivery system Biomed Microdevices 7 71 79 15834523 1:CAS:528:DC%2BD2MXjtlakt7k%3D (Pubitemid 40613133)
44. B Damascelli GL Patelli R Lanocita, et al. 2003 A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings AJR Am J Roentgenol 181 253 260 12818869 (Pubitemid 36741497)
45. H Nobuto T Sugita T Kubo, et al. 2004 Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet Int J Cancer 109 627 635 14991586 1:CAS:528:DC%2BD2cXislCis7g%3D (Pubitemid 38339655)
46. AJ Lemke MI Senfft von Pilsach A Lübbe, et al. 2004 MRI after magnetic drug targeting in patients with advanced solid malignant tumours Eur Radiol 14 1949 1955 15300401 (Pubitemid 39481162)
47. MO Avilés AD Ebner JA Ritter 2009 In vitro study of magnetic particle seeding for implant-assisted magnetic drug targeting: seed and magnetic drug carrier particle capture J Magn Magn Mater 321 1586 1590
48. A Luciani C Wilhelm P Bruneval, et al. 2009 Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver Eur Radiol 19 1087 1096 19137308
49. U Mahmood 2004 Can MR imaging be used to track delivery of intravascularly administered stem cells Radiology 233 625 626 15564396
50. AJ Dick MA Guttman VK Raman, et al. 2003 Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine Circulation 108 2899 2904 14656911 (Pubitemid 37517818)
51. JW Bulte T Douglas B Witwer, et al. 2001 Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells Nat Biotechnol 19 1141 1147 11731783 1:CAS:528:DC%2BD3MXptV2rt7Y%3D (Pubitemid 33115700)
52. HE Rice EW Hsu H Sheng, et al. 2007 Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice AJR Am J Roentgenol 188 1101 1108 17377054 (Pubitemid 46496950)
53. C Bos Y Delmas A Desmoulière, et al. 2004 In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver Radiology 233 781 789 15486216
54. GA Husseini WG Pitt 2008 Micelles and nanoparticles for ultrasonic drug and gene delivery Adv Drug Deliv Rev 60 1137 1152 18486269 1:CAS:528: DC%2BD1cXmsFKrtLs%3D
55. KW Ferrara 2008 Driving delivery vehicles with ultrasound Adv Drug Deliv Rev 60 1097 1102 18479775 1:CAS:528:DC%2BD1cXmsFKrtLw%3D
56. N Rapoport Z Gao A Kennedy 2007 Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy J Natl Cancer Inst 99 1095 1106 17623798 1:CAS:528:DC%2BD2sXpsVKmtbo%3D (Pubitemid 47241394)
57. PA Dayton S Zhao SH Bloch, et al. 2006 Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy Mol Imaging 5 160 174 16954031
58. JL Nelson BL Roeder JC Carmen, et al. 2002 Ultrasonically activated chemotherapeutic drug delivery in a rat model Cancer Res 62 7280 7283 12499270 1:CAS:528:DC%2BD3sXhtV2jsg%3D%3D (Pubitemid 36025250)
59. G Myhr J Moan 2006 Synergistic and tumour selective effects of chemotherapy and ultrasound treatment Cancer Lett 232 206 213 16458117 1:CAS:528:DC%2BD28XhtFWhu7o%3D (Pubitemid 43170970)
60. Z Gao HD Fain N Rapoport 2005 Controlled and targeted tumor chemotherapy by micellar-encapusulated drug and ultrasound J Control Release 102 203 222 15653146 1:CAS:528:DC%2BD2MXktVGiug%3D%3D (Pubitemid 40093786)
61. U Pison T Welte M Giersig, et al. 2006 Nanomedicine for respiratory disease Eur J Pharmacol 533 1-3 341 350 16434033 1:CAS:528:DC%2BD28XitVKgs7k%3D
62. S Azarmi WH Roa R Lobenberg 2008 Targeted delivery of nanoparticles for the treatment of lung diseases Adv Drug Deliv Rev 60 863 875 18308418 1:CAS:528:DC%2BD1cXlslagu70%3D
63. JN Marsh A Senpan G Hu, et al. 2007 Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis Nanomedicine 2 533 543 17716136 1:CAS:528:DC%2BD2sXpsVaqurY%3D (Pubitemid 47365128)
64. G Lanza P Winter T Cyrus, et al. 2006 Nanomedicine opportunities in cardiology Ann N Y Acad Sci 1080 451 465 17132801 1:CAS:528: DC%2BD2sXmtlymsw%3D%3D (Pubitemid 44955439)
65. N Gerwin C Hops A Lucke 2006 Intraarticular drug delivery in osteoarthritis Adv Drug Deliv Rev 58 226 242 16574267 1:CAS:528: DC%2BD28XksVaju78%3D
66. PM Mountziaris PR Kramer AG Mikos 2009 Emerging intra-articular drug delivery systems for the temporomandibular joint Methods 47 134 140 18835358 1:CAS:528:DC%2BD1MXht1SnsA%3D%3D
67. E Horisawa T Hirota S Kawazoe, et al. 2002 Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit Pharm Res 19 403 410 12033371 1:CAS:528:DC%2BD38XjvFejsr0%3D (Pubitemid 34408936)
68. JD Raman DW Hall JA Cadeddu 2009 Renal ablative therapy: radiofrequency ablation and cryoablation J Surg Oncol 100 639 644 20017159
69. DP O'Neal LR Hirsch NJ Halas, et al. 2004 Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles Cancer Lett 209 171 176 15159019 (Pubitemid 38670486)
70. B Hildebrandt P Wust O Ahlers, et al. 2002 The cellular and molecular basis of hyperthermia Crit Rev Oncol Hematol 43 33 56 12098606 (Pubitemid 34722786)
71. I Hilger R Hergt WA Kaiser 2005 Use of magnetic nanoparticle heating in the treatment of breast cancer IEE Proc Nanobiotechnol 152 33 39 16441156 1:STN:280:DC%2BD28%2FlvVaqsw%3D%3D (Pubitemid 40453794)
72. M Johannsen U Gneveckow K Taymoorian, et al. 2007 Thermal therapy of prostate cancer using magnetic nanoparticles Actas Urol Esp 31 660 667 17896563
73. S Takamatsu O Matsui T Gabata, et al. 2008 Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits Radiat Med 26 179 187 18509717 1:CAS:528:DC%2BD1cXotlGisLg%3D (Pubitemid 351754720)
74. M Johannsen U Gneveckow B Thiesen, et al. 2007 Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three dimensional temperature distribution Eur Urol 52 1653 1661 17125906
75. I Hilger W Andrä R Hergt, et al. 2001 Electromagnetic heating of breast tumours in interventional radiology: in vitro and in vivo studies in human cadavers and mice Radiology 218 570 575 11161180 1:STN:280: DC%2BD3M3lvVehsA%3D%3D (Pubitemid 32121077)
76. M Ahmed WE Monsky G Girnun, et al. 2003 Radiofrequency thermal ablation sharply increases intratumoural liposomal doxorubicin accummulation and tumor coagulation Cancer Res 63 6327 6333 14559820 1:CAS:528:DC%2BD3sXotV2ju7g%3D (Pubitemid 37255180)
77. SN Goldberg GD Girnan AN Lukyanov, et al. 2002 Percutaneous tumor ablation: increased necrosis with combined radiofrequency ablation and intravenous liposomal doxorubicin in a rat breast tumour model Radiology 222 797 804 11867804 (Pubitemid 34215233)
78. SN Goldberg IR Kamel JB Kruskal, et al. 2002 Radiofrequency ablation of hepatic tumours: increased tumour destruction with adjuvant liposomal doxorubicin therapy AJR Am J Roentgenol 179 93 101 12076912 (Pubitemid 34694817)
79. M Ahmed Z Liu AN Lukyanov, et al. 2005 Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accummulation and coagulation in multiple tissues and tumor types in animals Radiology 235 469 477 15858089 (Pubitemid 40571084)
80. M Ahmed AN Lukyanov V Torchilin, et al. 2005 Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time J Vasc Interv Radiol 16 1365 1371 16221908 (Pubitemid 41463995)
81. DF Kong PJ Goldschmidt-Clermont 2005 Tiny solutions for giant cardiac problems Trends Cardiovasc Med 15 207 211 16182130 (Pubitemid 41338007)
82. GW Stone SG Ellis DA Cox, et al. 2004 A polymer-based paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 221 231 14724301 1:CAS:528:DC%2BD2cXkvVKmtQ%3D%3D (Pubitemid 38067635)
83. MN Babapulle L Joseph P Bélisle, et al. 2004 A hierarchical bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 9434 583 591 15313358 1:CAS:528:DC%2BD2cXmslaltrg%3D (Pubitemid 39094175)
84. GW Stone SG Ellis DA Cox, et al. 2004 One-year clinical results with the slow-release, polymer based, paclitaxel-eluting TAXUS stent. The TAXUS-IV trial Circulation 109 1942 1947 15078803 1:CAS:528:DC%2BD2cXjtFOmt74%3D (Pubitemid 38544483)
85. AJ Lansky RA Costa GS Mintz, et al. 2004 Non-polymer-based paclitaxel-coated coronary stents for the treatment of pateints with de novo coronary lesions. Angiographic follow-up of the DELIVER clinical trial Circulation 109 1948 1954 15078794 1:CAS:528:DC%2BD2cXjtFOmt7w%3D (Pubitemid 38544484)
86. R Virmani F Liistro G Stankovic, et al. 2002 Mechanism of late in-stent restenosis after implantation of a paclitaxel derivative-eluting polymer stent system in humans Circulation 106 2649 2651 12438288 1:CAS:528: DC%2BD38XosFCrsrg%3D (Pubitemid 35364917)
87. WK Laskey CW Yancy WH Maisel 2007 Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006 Circulation 115 2352 2357 17470710 (Pubitemid 46685904)
88. JM Caves EL Chaikof 2006 The evolving impact of microfabrication and nanotechnology on stent design J Vasc Surg 44 1363 1368 17145446 (Pubitemid 44828420)
89. A Finkelstein D McClean S Kar, et al. 2003 Local drug delivery via a coronary stent with programmable release pharmacokinetics Circulation 107 777 784 12578884 (Pubitemid 36222609)
90. ML Reed C Wu J Kneller, et al. 1998 Micromechanical devices for intravascular drug delivery J Pharm Sci 87 1387 1394 9811495 1:CAS:528:DyaK1cXlvVSrt7k%3D (Pubitemid 28514146)
91. B Bhargava NK Reddy G Karthikeyan, et al. 2006 A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model Catheter Cardiovasc Interv 67 698 702 16575925
92. LA Guzman V Labhasetwar C Song, et al. 1996 Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty Circulation 94 1441 1448 8823004 1:CAS:528:DyaK28XlvFyhtb0%3D (Pubitemid 26307277)
93. FD Kolodgie M John C Khurana, et al. 2002 Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel Circulation 106 1118 1195
94. V Labhasetwar C Song W Humphrey, et al. 1998 Arterial uptake of biodegradable nanoparticles: effect of surface modifications J Pharm Sci 87 1229 1234 9758682 1:CAS:528:DyaK1cXls12gsrc%3D (Pubitemid 28455614)
95. GM Lanza PM Winter X Yu, et al. 2002 Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis Circulation 106 2842 2847 12451012 1:CAS:528:DC%2BD38XoslSnsb0%3D (Pubitemid 35396985)
96. PM Winter AM Morawski SD Caruthers, et al. 2003 Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles Circulation 108 2270 2274 14557370 1:CAS:528:DC%2BD3sXosVShs7c%3D (Pubitemid 37363046)
97. 3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler Thromb Vasc Biol 26 2103 2109 16825592 1:CAS:528:DC%2BD28XotVWlt78%3D (Pubitemid 44253795)
98. EA Sprague ML Pomeranz I Odess, et al. 2008 Surface material, surface treatment and nanotechnology in cardiovascular stent development EuroIntervention 4 Suppl C C60 C62 19202698
99. J Lu MP Rao NC MacDonald, et al. 2008 Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features Acta Biomater 4 192 201 17851147 1:CAS:528:DC%2BD1cXhtVekt77E (Pubitemid 350131559)
100. 2 nanonodular structures in a micro-to-nanoscale hierarchy model Biomaterials 30 5319 5329 19589591 1:CAS:528:DC%2BD1MXpvFCgtL8%3D
101. D Khang J Lu C Yao, et al. 2008 The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium Biomaterials 29 970 983 18096222 1:CAS:528:DC%2BD2sXhsVGltb3P (Pubitemid 50020176)
102. DC Miller KM Haberstroh TJ Webster 2005 Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films J Biomed Mater Res A 73A 476 484 1:CAS:528:DC%2BD2MXlt1yjsLs%3D (Pubitemid 40791395)
103. DC Miller A Thapa KM Haberstroh, et al. 2004 Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features Biomaterials 25 53 61 14580908 1:CAS:528:DC%2BD3sXot1SktLw%3D (Pubitemid 37324400)
104. H Liu TJ Webster 2006 Nanomedicine for implants: a review of studies and necessary experimental tools Biomaterials 28 354 369 17049982 1:CAS:528:DC%2BD2sXhsVyntLzF
105. J Aoki PW Serruys H van Beusekom, et al. 2005 Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry J Am Coll Cardiol 45 1574 1579 15893169 1:CAS:528:DC%2BD2MXktVOjsbY%3D (Pubitemid 40704488)
106. JI Rotmans JM Heyligers HJ Verhagen, et al. 2005 In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts Circulation 112 12 18 15983250 1:CAS:528:DC%2BD2MXlsF2itLY%3D (Pubitemid 40962563)
107. CT Lo PR Van Tassel WM Saltzman 2009 Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices Biomaterials 30 4889 4897 19592089 1:CAS:528:DC%2BD1MXpt1CisLs%3D
108. OD Krishna K Kim Y Byun 2005 Covalently grafted phospholipid monolayer on silicone catheter surface for reduction in platelet adhesion Biomaterials 26 7115 7123 16009416 1:CAS:528:DC%2BD2MXmvFCqurc%3D (Pubitemid 41095533)
109. RG Ellis-Behnke Y Liang DK Tay, et al. 2006 Nano hemostat solution: immediate hemostasis at the nanoscale Nanomedicine 2 207 215 17292144 (Pubitemid 44895530)
110. CK Holland SS Vaidya S Datta, et al. 2008 Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model Thromb Res 121 663 673 17854867 1:CAS:528:DC%2BD1cXislamt74%3D (Pubitemid 351308146)
111. C Wissgott A Richter P Kamusella, et al. 2007 Treatment of critcal limb ischaemia using ultrasound enhanced thrombolysis (PARES Trial): final results J Endovasc Ther 14 433 438
112. S Parikh A Motarjeme T McNamara, et al. 2008 Ultrasound-accelerated thrombolysis for the treatment of deep venous thrombosis: initial clinical experience J Vasc Interv Radiol 19 521 528 18375296 (Pubitemid 351424912)
113. AV Alexandrov CA Molina JC Grotta, et al. 2004 Ultrasound-enhanced systemic thrombolysis for acute ischaemic stroke N Engl J Med 351 21 2170 2178 15548777 1:CAS:528:DC%2BD2cXhtVSqtLzO (Pubitemid 39507629)
114. CA Molina M Ribo M Rubiera, et al. 2006 Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator Stroke 37 425 429 16373632 1:CAS:528:DC%2BD28XlvVCmsw%3D%3D (Pubitemid 43731999)
115. WC Culp TR Porter TC McCowan, et al. 2003 Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs J Vasc Interv Radiol 14 343 347 12631639 (Pubitemid 36314763)
116. ST Laing DD McPherson 2009 Cardiovascular therapeutic uses of targeted ultrasound contrast agents Cardiovasc Res 83 626 635 19581314 1:CAS:528:DC%2BD1MXhtVWitrjO
117. SD Tiukinhoy-Laing K Buchanan D Parikh, et al. 2007 Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes J Drug Target 15 109 114 17365281 1:CAS:528:DC%2BD2sXjt1Cgt7k%3D (Pubitemid 46957696)
118. SD Tiukinhoy-Laing S Huang M Klegerman, et al. 2007 Ultrasound- facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes Thromb Res 119 777 784 16887172 1:CAS:528:DC%2BD2sXjsVGis7Y%3D (Pubitemid 46441423)
119. K Thomas P Aguar H Kawasaki, et al. 2006 Research strategies for safety evaulation of nanomaterials, part VIII: international efforts to develop risk-based safety evaluations for nanomaterials Toxicol Sci 92 23 32 16687392 1:CAS:528:DC%2BD28XmsVegs7c%3D (Pubitemid 43985786)
120. PJA Borm D Robbins S Haubold, et al. 2006 The potential risks of nanomaterials: a review carried out for ECETOC Part Fibre Toxicol 3 11 16907977
121. J Curtis M Greenberg J Kester, et al. 2006 Nanotechnology and nanotoxicology: a primer for clinicians Toxicol Rev 25 245 260 17288496 1:CAS:528:DC%2BD2sXjs1GksrY%3D
122. CW Lam JT James R McCluskey, et al. 2004 Pulmonary toxicity of single walled carbon nanotubes in mice 7 and 90 days after intratracheal instillation Toxicol Sci 77 126 134 14514958 1:CAS:528:DC%2BD2cXnslKk (Pubitemid 38128652)
123. 2, SiC nanoparticles and multi-walled carbon nanotubed exposure in several mammalian cell types: an in vitro study J Nanopart Res 12 61 73 1:CAS:528:DC%2BC3cXos1Onuw%3D%3D
124. B Wang W Feng M Zhu, et al. 2009 Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice J Nanopart Res 11 41 53
125. CL Villiers H Freitas R Couderc, et al. 2010 Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions J Nanopart Res 12 55 60 1:CAS:528:DC%2BC3cXos1Olug%3D%3D
126. KO Yu CM Grabinski AM Schrand, et al. 2009 Toxicity of amorphous silica nanoparticles in mouse keratinocytes J Nanopart Res 11 15 24 1:CAS:528:DC%2BD1MXhtlSksg%3D%3D
127. RA Freitas Jr. 2005 Nanotechnology, nanomedicine and nanosurgery Int J Surg 3 243 246 17462292 (Pubitemid 43136471)
128. JB Mathieu G Beaudoin S Martel 2006 Method of propulsion of a ferromagnetic core in the cardiovascular system through magnetic gradients generated by an MRI system IEEE Trans Biomed Eng 53 292 299 16485758 (Pubitemid 43168160)
129. A Cavalcanti B Shirinzadeh FA Freitas Jr, et al. 2008 Nanorobot architecture for medical target identification Nanotechnology 19 015103